Endosonography-Guided Versus Percutaneous Gallbladder Drainage Versus Cholecystectomy in Fragile Patients with Acute Cholecystitis-A High-Volume Center Study
Background and Objectives: Acute cholecystitis is a frequent cause of admission to the emergency department, especially in old and frail patients. Percutaneous drainage (PT-GBD) and endosonographic guided drainage (EUS-GBD) could be an alternative option for relieving symptoms or act as a definitive treatment instead of a laparoscopic or open cholecystectomy (LC, OC). The aim of the present study was to compare different treatment groups. Materials and Methods: This is a five-year monocentric retrospective study including patients ≥65 years old who underwent an urgent operative procedure. A descriptive analysis was conducted comparing all treatment groups. A propensity score was estimated based on the ACS score, incorporated into a predictive model, and tested by recursive partitioning analysis. Results: 163 patients were included: 106 underwent a cholecystectomy (81 laparoscopic (LC) and 25 Open (OC)), 33 a PT-GBD and 21 EUS-GBD. The sample was categorized into three prognostic groups according to the adverse event occurrence rate. All patients treated with EUS-GBD or LC resulted in the low risk group, and the adverse event rate (AE) was 10/96 (10.4%). The AE was 4/28 (14.2%) and 21/36 (58.3%) in the middle- and high-risk groups respectively (p < 0.001). These groups included all the patients who underwent an OC or a PT-GBD. The PT-GBD group had a lower clinical success rate (55.5%) and higher RR (16,6%) when compared with other groups. Conclusions: Surgery still represents the gold standard for AC treatment. Nevertheless, EUS-GBD is a good alternative to PT-GBD in terms of clinical success, RR and AEs in all kinds of patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
---|---|
Enthalten in: |
Medicina (Kaunas, Lithuania) - 58(2022), 11 vom: 14. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kurihara, Hayato [VerfasserIn] |
---|
Links: |
---|
Themen: |
ACS score |
---|
Anmerkungen: |
Date Completed 28.11.2022 Date Revised 08.03.2023 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/medicina58111647 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM349352593 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM349352593 | ||
003 | DE-627 | ||
005 | 20231226042420.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/medicina58111647 |2 doi | |
028 | 5 | 2 | |a pubmed24n1164.xml |
035 | |a (DE-627)NLM349352593 | ||
035 | |a (NLM)36422184 | ||
035 | |a (PII)1647 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kurihara, Hayato |e verfasserin |4 aut | |
245 | 1 | 0 | |a Endosonography-Guided Versus Percutaneous Gallbladder Drainage Versus Cholecystectomy in Fragile Patients with Acute Cholecystitis-A High-Volume Center Study |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.11.2022 | ||
500 | |a Date Revised 08.03.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background and Objectives: Acute cholecystitis is a frequent cause of admission to the emergency department, especially in old and frail patients. Percutaneous drainage (PT-GBD) and endosonographic guided drainage (EUS-GBD) could be an alternative option for relieving symptoms or act as a definitive treatment instead of a laparoscopic or open cholecystectomy (LC, OC). The aim of the present study was to compare different treatment groups. Materials and Methods: This is a five-year monocentric retrospective study including patients ≥65 years old who underwent an urgent operative procedure. A descriptive analysis was conducted comparing all treatment groups. A propensity score was estimated based on the ACS score, incorporated into a predictive model, and tested by recursive partitioning analysis. Results: 163 patients were included: 106 underwent a cholecystectomy (81 laparoscopic (LC) and 25 Open (OC)), 33 a PT-GBD and 21 EUS-GBD. The sample was categorized into three prognostic groups according to the adverse event occurrence rate. All patients treated with EUS-GBD or LC resulted in the low risk group, and the adverse event rate (AE) was 10/96 (10.4%). The AE was 4/28 (14.2%) and 21/36 (58.3%) in the middle- and high-risk groups respectively (p < 0.001). These groups included all the patients who underwent an OC or a PT-GBD. The PT-GBD group had a lower clinical success rate (55.5%) and higher RR (16,6%) when compared with other groups. Conclusions: Surgery still represents the gold standard for AC treatment. Nevertheless, EUS-GBD is a good alternative to PT-GBD in terms of clinical success, RR and AEs in all kinds of patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a ACS score | |
650 | 4 | |a cholecystectomy | |
650 | 4 | |a cholecystitis | |
650 | 4 | |a endosonography-guided gallbladder drainage | |
650 | 4 | |a frailty | |
650 | 4 | |a percutaneous gallbladder drainage | |
700 | 1 | |a Bunino, Francesca M |e verfasserin |4 aut | |
700 | 1 | |a Fugazza, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Marrano, Enrico |e verfasserin |4 aut | |
700 | 1 | |a Mauri, Giulia |e verfasserin |4 aut | |
700 | 1 | |a Ceolin, Martina |e verfasserin |4 aut | |
700 | 1 | |a Lanza, Ezio |e verfasserin |4 aut | |
700 | 1 | |a Colombo, Matteo |e verfasserin |4 aut | |
700 | 1 | |a Facciorusso, Antonio |e verfasserin |4 aut | |
700 | 1 | |a Repici, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Anderloni, Andrea |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Medicina (Kaunas, Lithuania) |d 1998 |g 58(2022), 11 vom: 14. Nov. |w (DE-627)NLM093687583 |x 1648-9144 |7 nnns |
773 | 1 | 8 | |g volume:58 |g year:2022 |g number:11 |g day:14 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/medicina58111647 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 58 |j 2022 |e 11 |b 14 |c 11 |